During the past decade, iOMEDICO AG conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "iOMEDICO AG" #1 collaborator was "Arbeitsgemeinschaft fur Internistische Onkologie" with 3 trials as a collaborator, "Arbeitskreis Klinische Studien" with 2 trials as a collaborator, "Novartis Pharmaceuticals" with 2 trials as a collaborator, "ASORS" with 1 trials as a collaborator and "ASORS (Arbeitsgemeinschaft Supportive Maßnahmen in der Onkologie, Rehabilitation und Sozialmedizin der Deutschen Krebsgesellschaft)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "iOMEDICO AG" are "AML" (1 trials), "Advanced Breast Cancer" (1 trials), "Anemia" (1 trials), "Antiemetic Therapy" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "iOMEDICO AG" in a lesser frequency.

Most popular intervention types in "iOMEDICO AG" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "BKM120" (1 trials), "Bevacizumab" (1 trials), "Capecitabine" (1 trials), "Docetaxel" (1 trials) and "Everolimus" (1 trials). Other intervention names were less common.

The vast majority of trials in "iOMEDICO AG" are 5 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "iOMEDICO AG". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in iOMEDICO AG, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in iOMEDICO AG, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".